ArticleRSC advances2026

2-Oxoindoline-based hydroxamic acids: novel HDAC inhibitors with promising anticancer activity.

Tran Thi Lan Huong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.